Fleig Claudia, Evert Katja, Schlitt Hans J, Fichtner-Feigl Stefan, Brunner Stefan M
Department of Surgery, University Medical Center Regensburg, 93053 Regensburg, Germany.
Institute of Pathology, University Regensburg, 93053 Regensburg, Germany.
Cancers (Basel). 2023 Feb 7;15(4):1056. doi: 10.3390/cancers15041056.
Colorectal liver metastases (CRLM) can be encased in a fibrous capsule separating cancer from normal liver tissue, which correlates with increased patient survival. This study investigated the cellular and molecular components of capsule formation and the possible role of epithelial mesenchymal transition (EMT). From 222 patients with CRLM, 84 patients (37.8%) were categorized to have CRLM encased with a capsule. A total of 34 CRLM from 34 selected patients was analyzed in detail by EMT pathway-profiling and custom PCR arrays to identify differences in gene expression between CRLM with (n = 20) and without capsule (n = 14). In parallel, those 34 CRLM were used to analyze 16 gene products at the metastasis margin via immunohistochemistry. Encapsulated CRLM showed an elevated expression of signal transduction pathways and effector molecules involved in EMT. E-cadherin and keratin-19 were more prevalent, and transcription as well as translation (immunohistochemistry) of pGSK-3-β, SOX10, tomoregulin-1, and caldesmon were increased. By contrast, the loss of E-cadherin and the prevalence of snail-1 were increased in CRLM without capsule. Collagen I and III and versican were identified as capsule components with extracellular matrix fibers running concentrically around the malignant tissue and parallel to the invasive front. Caldesmon was also demonstrated as a capsule constituent. The fibrous capsule around CRLM can be produced by cells with mesenchymal characteristics. It functions as a protective border by both the features of fiber architecture and the inhibition of invasive growth through EMT recruiting mesenchymal cells such as myofibroblasts by transformation of surrounding epithelial or even carcinoma cells. By contrast, EMT demonstrated in non-encapsulated CRLM may lead to a more mesenchymal, mobile, and tissue-destructive carcinoma cell phenotype and facilitate malignant spread.
结直肠癌肝转移(CRLM)可能被包裹在一层纤维性包膜中,该包膜将癌组织与正常肝组织分隔开来,这与患者生存率的提高相关。本研究调查了包膜形成的细胞和分子成分以及上皮-间质转化(EMT)的可能作用。在222例CRLM患者中,84例(37.8%)被归类为有包膜包裹的CRLM。通过EMT通路分析和定制PCR芯片对34例选定患者的34个CRLM进行了详细分析,以确定有包膜(n = 20)和无包膜(n = 14)的CRLM之间的基因表达差异。同时,利用这34个CRLM通过免疫组化分析转移边缘的16种基因产物。有包膜的CRLM显示出与EMT相关的信号转导通路和效应分子的表达升高。E-钙黏蛋白和角蛋白-19更为普遍,pGSK-3-β、SOX10、tomoregulin-1和钙调蛋白的转录以及翻译(免疫组化)均增加。相比之下,无包膜的CRLM中E-钙黏蛋白的缺失和snail-1的普遍程度增加。I型和III型胶原蛋白以及多功能蛋白聚糖被确定为包膜成分,细胞外基质纤维围绕恶性组织呈同心圆排列并与侵袭前沿平行。钙调蛋白也被证明是包膜的组成成分。CRLM周围的纤维性包膜可由具有间充质特征的细胞产生。它通过纤维结构特征以及通过EMT招募间充质细胞(如肌成纤维细胞)来抑制侵袭性生长,从而起到保护边界的作用,这种EMT是通过周围上皮细胞甚至癌细胞的转化实现的。相比之下,在无包膜的CRLM中表现出的EMT可能导致更具间充质、移动性和组织破坏性的癌细胞表型,并促进恶性扩散。